Menopause and nutraceuticals

Franco Vicariotto


Full Text



  • Veling M. Regulatory information resources for nutraceuticals and functional foods: resource guide. © 2012 National Research Council of Canada. Available at〈=en&fd=main&ext=. (last accessed July 2015)
  • Ufficio stampa IMS Health Italia. IMS Health Italia: Nutraceutica - Italia uno dei mercati europei più maturi. Bologna, 17 aprile 2014. Available at (last accessed July 2015)
  • IMS Health Italia. Nutraceutica forum, 2015. Milano, 16 giugno 2015
  • Franconi F, Montilla S, Vella S. Farmacologia di genere. Torino: SEEd Medical Publishers, 2010
  • Ufficio stampa IMS Health Italia. IMS Health Italia: FARMACIA - nei primi due mesi del 2015 il mercato commerciale è cresciuto del 3,7%. Bologna, 17 aprile 2015. Available at (last accessed July 2015)
  • AbouZahr C. Progress and challenges in women’s health: an analysis of levels and patterns of mortality and morbidity. Contraception 2014; 90: S3-S13;
  • Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas 2010; 66: 333-43;
  • Hulley S, Grady D, Bush T, et al.; for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13;
  • Writing Group for the Women’s Health Initiative Investigators; Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33;
  • GoPubMed. Available at (last accessed July 2015)


Abstract: 783 views
HTML: 422 views
PDF: 265 views


  • There are currently no refbacks.